Matthias Schiell

Title: Matthias Schiell: Innovator in Pharmaceutical Compounds

Introduction

Matthias Schiell is a notable inventor based in Brechen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 6 patents to his name, Schiell's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents, Schiell has developed compounds represented by the formula IAcPhe-Aib-Aib-Aib-x-w-Leu-y-Aib-Hyp-Gln-z-Hyp-Aib-Pro-R. In this formula, R is either Phe-ol or Phe-al, and the variables w, x, y, and z denote specific meanings. Another significant invention involves Gabusectin derivatives, which includes processes for their preparation and use. This invention relates to compounds formed by the microorganism ST 003236 (DSM 14476) during fermentation, along with a process for preparing and derivatizing them. These compounds are also utilized in pharmaceuticals, showcasing their potential in medical applications.

Career Highlights

Throughout his career, Matthias Schiell has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Aventis Pharma Deutschland GmbH and Hoechst Marion Roussel Deutschland GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Schiell has collaborated with several professionals in his field, including Laszlo Vertesy and Michael Kurz. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Matthias Schiell's contributions to pharmaceutical compounds and his innovative patents reflect his dedication to advancing medical science. His work continues to influence the industry and pave the way for future developments.